The stock market performance of Viracta Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $2.38 on 05/22/23, while the lowest price during the same time frame was $0.43, recorded on 12/19/23.
52-week price history of VIRX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Viracta Therapeutics Inc’s current trading price is -67.23% away from its 52-week high, while its distance from the 52-week low is 81.40%. The stock’s price range for this period has remained between $0.43 and $2.38. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.6 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.1 million over the last three months.
Financial Performance and Market Capitalization
Viracta Therapeutics Inc (VIRX) has experienced a quarterly rise of 31.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.63M and boasts a workforce of 40 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7035, with a change in price of +0.2007. Similarly, Viracta Therapeutics Inc recorded 146,879 in trading volume during the last 100 days, posting a change of +34.65%.
VIRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VIRX stands at 1.40. Similarly, the long-term debt-to-equity ratio is also 0.00.
VIRX Stock Stochastic Average
As of today, the raw stochastic average of Viracta Therapeutics Inc over the last 50 days is at 31.17%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 3.64%. Further, the company’s Stochastic %K and %D values for the last 20 days were 41.02% and 59.21%, respectively.
VIRX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 36.84%.However, over the last six months, we can see a weaker performance of 2.77%. Over the last 30 days, the price of VIRX has leaped by -19.59%. And in the last five days, it has fallen by -27.10%.
